KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Other financing activities (2018 - 2025)

Historic Other financing activities for Exact Sciences (EXAS) over the last 11 years, with Q3 2025 value amounting to -$1.7 million.

  • Exact Sciences' Other financing activities rose 2616.62% to -$1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.4 million, marking a year-over-year increase of 3055.98%. This contributed to the annual value of -$17.8 million for FY2024, which is 8207.36% down from last year.
  • Per Exact Sciences' latest filing, its Other financing activities stood at -$1.7 million for Q3 2025, which was up 2616.62% from -$1.8 million recorded in Q2 2025.
  • In the past 5 years, Exact Sciences' Other financing activities registered a high of -$417000.0 during Q4 2022, and its lowest value of -$11.6 million during Q2 2024.
  • For the 5-year period, Exact Sciences' Other financing activities averaged around -$2.6 million, with its median value being -$1.7 million (2021).
  • In the last 5 years, Exact Sciences' Other financing activities plummeted by 90363.64% in 2024 and then skyrocketed by 8412.7% in 2025.
  • Exact Sciences' Other financing activities (Quarter) stood at -$544000.0 in 2021, then increased by 23.35% to -$417000.0 in 2022, then crashed by 443.65% to -$2.3 million in 2023, then rose by 2.51% to -$2.2 million in 2024, then grew by 21.22% to -$1.7 million in 2025.
  • Its Other financing activities was -$1.7 million in Q3 2025, compared to -$1.8 million in Q2 2025 and -$6.6 million in Q1 2025.